Literature DB >> 25663786

Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Qing Pang1, Jing-Yao Zhang1, Si-Dong Song1, Kai Qu1, Xin-Sen Xu1, Su-Shun Liu1, Chang Liu1.   

Abstract

AIM: To investigate whether central obesity is associated with nonalcoholic fatty liver disease (NAFLD) formation after adjusting for general obesity.
METHODS: The online databases PubMed, EMBASE, and ISI Web of Science were searched for studies estimating the influence of central obesity on NAFLD occurrence published through April 2014. Studies that did not adjust for body mass index (BMI) were excluded. In addition, the independent effect of BMI was also assessed with the included studies. The pooled effect sizes and 95% confidence intervals (CIs) were calculated using random- or fixed-effects models based on the degree of heterogeneity. Furthermore, subgroup analyses, meta-regression, sensitivity analyses, and publication bias were performed.
RESULTS: Twenty eligible studies were identified. The summary odds ratio (OR) values per-unit increase in waist circumference (WC) and BMI for NAFLD formation were 1.07 (95%CI: 1.03-1.10, I (2) = 73.9%, n = 11 studies) and 1.25 (95%CI: 1.13-1.38, I (2) = 88.7%, n = 11 studies), respectively. When the indices were expressed as binary variables (with the non-obesity group as reference), the pooled OR in WC, waist-to-hip ratio, and BMI were 2.34 (95%CI: 1.83-3.00, I (2) = 41.8%, n = 7 studies), 4.06 (95%CI: 1.53-10.79, I (2) = 65.7%, n = 3 studies), and 2.85 (95%CI: 1.60-5.08, I (2) = 57.8%, n = 5 studies), respectively. Using the same studies as the latter (n = 5), pooled OR in WC was 3.14 (95%CI: 2.07-4.77), which is greater than that in BMI.
CONCLUSION: Central obesity may pose a greater threat to national health than general obesity, although both are independently associated with increased risk of NAFLD.

Entities:  

Keywords:  Body mass index; Central obesity; General obesity; Nonalcoholic fatty liver disease; Waist circumference

Mesh:

Year:  2015        PMID: 25663786      PMCID: PMC4316109          DOI: 10.3748/wjg.v21.i5.1650

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  85 in total

1.  [Associations of non alcoholic fatty liver with the metabolic syndrome and serum carotenoids].

Authors:  Sun Kyun Park; Hyun Jung Lee; Duk Hee Lee; Sung Kook Lee; Byung Yeol Chun; Sung Ae Kim; Hye Sung Lee; Hyo Kyung Son; Sung Hi Kim
Journal:  J Prev Med Public Health       Date:  2008-01

2.  Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation.

Authors:  C Kim; S D Harlow; C A Karvonen-Gutierrez; J F Randolph; M Helmuth; S Kong; B Nan; R Carlos
Journal:  Diabet Med       Date:  2013-06-07       Impact factor: 4.359

Review 3.  Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.

Authors:  Andreas Schäffler; Jürgen Schölmerich; Christa Büchler
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-06

Review 4.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

5.  Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease.

Authors:  Chung-Huang Tsai; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  South Med J       Date:  2008-09       Impact factor: 0.954

6.  Adiponectin negatively correlates with alcoholic and non-alcoholic liver dysfunction: Health check-up study of Japanese men.

Authors:  Mina Hamano; Yoshihiro Kamada; Shinichi Kiso; Kunimaro Furuta; Takashi Kizu; Norihiro Chatani; Mayumi Egawa; Takayo Takemura; Hisao Ezaki; Yuichi Yoshida; Kenji Watabe; Toshimitsu Hamasaki; Miyuki Umeda; Aiko Furubayashi; Kazuo Kinoshita; Osamu Kishida; Takashi Fujimoto; Akira Yamada; Yoshifumi Tsukamoto; Shusaku Tsutsui; Tetsuo Takehara; Norio Hayashi; Yuji Matsuzawa
Journal:  Hepatol Res       Date:  2012-07-26       Impact factor: 4.288

7.  Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.

Authors:  V Mohan; S Farooq; M Deepa; R Ravikumar; C S Pitchumoni
Journal:  Diabetes Res Clin Pract       Date:  2009-01-24       Impact factor: 5.602

8.  Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up.

Authors:  Yuan-Lung Cheng; Yuan-Jen Wang; Wei-Yu Kao; Ping-Hsien Chen; Teh-Ia Huo; Yi-Hsiang Huang; Keng-Hsin Lan; Chien-Wei Su; Wan-Leong Chan; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

9.  Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.

Authors:  Abigail Fraser; Matthew P Longnecker; Debbie A Lawlor
Journal:  Gastroenterology       Date:  2007-09-02       Impact factor: 22.682

10.  Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults.

Authors:  Xin Ying; Yan Jiang; Yafang Qian; Zhenyan Jiang; Zhenya Song; Changjun Zhao
Journal:  Iran J Public Health       Date:  2012-01-31       Impact factor: 1.429

View more
  36 in total

Review 1.  The Science of Obesity Management: An Endocrine Society Scientific Statement.

Authors:  George A Bray; William E Heisel; Ashkan Afshin; Michael D Jensen; William H Dietz; Michael Long; Robert F Kushner; Stephen R Daniels; Thomas A Wadden; Adam G Tsai; Frank B Hu; John M Jakicic; Donna H Ryan; Bruce M Wolfe; Thomas H Inge
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

2.  What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?

Authors:  Mariana V Machado; Sara Policarpo; J Coutinho; Sofia Carvalhana; Jorge Leitão; Armando Carvalho; Ana P Silva; Francisco Velasco; Isabel Medeiros; Ana Catarina Alves; Mafalda Bourbon; Helena Cortez-Pinto
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

Review 3.  Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology.

Authors:  Davide Gnocchi; Carlo Custodero; Carlo Sabbà; Antonio Mazzocca
Journal:  J Mol Med (Berl)       Date:  2019-04-05       Impact factor: 4.599

4.  Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.

Authors:  Kushala W M Abeysekera; James G Orr; Fiona H Gordon; Laura D Howe; Julian Hamilton-Shield; Jon Heron; Matthew Hickman
Journal:  BMC Gastroenterol       Date:  2022-06-30       Impact factor: 2.847

5.  Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.

Authors:  Sofía Montemayor; Cristina Bouzas; Catalina M Mascaró; Miguel Casares; Isabel Llompart; Itziar Abete; Escarlata Angullo-Martinez; María Ángeles Zulet; J Alfredo Martínez; Josep A Tur
Journal:  Nutrients       Date:  2022-05-26       Impact factor: 6.706

6.  Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.

Authors:  Maobin Kuang; Song Lu; Qiyang Xie; Nan Peng; Shiming He; Changhui Yu; Jiajun Qiu; Guotai Sheng; Yang Zou
Journal:  BMC Gastroenterol       Date:  2022-06-25       Impact factor: 2.847

7.  The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.

Authors:  Maobin Kuang; Guotai Sheng; Chong Hu; Song Lu; Nan Peng; Yang Zou
Journal:  Lipids Health Dis       Date:  2022-10-20       Impact factor: 4.315

8.  Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial.

Authors:  James L Dorling; Eric Ravussin; Leanne M Redman; Manju Bhapkar; Kim M Huffman; Susan B Racette; Sai K Das; John W Apolzan; William E Kraus; Christoph Höchsmann; Corby K Martin
Journal:  Eur J Nutr       Date:  2020-08-14       Impact factor: 5.614

9.  A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease.

Authors:  Cecilia C Garcia; Bárbara Piotrkowski; Plácida Baz; Daniel Poncino; Javier Benavides; Luis Colombato; María Laura Reyes Toso; Silvina Yantorno; Valeria Descalzi; Gabriel E Gondolesi; Cesar G Fraga; Alejandra C Cherñavsky
Journal:  Dig Dis Sci       Date:  2021-06-22       Impact factor: 3.487

10.  Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study.

Authors:  Kyung Eun Yun; Ga Eun Nam; Jisun Lim; Hye Soon Park; Yoosoo Chang; Hyun-Suk Jung; Chan-Won Kim; Byung-Joon Ko; Eun Chul Chung; Hocheol Shin; Seungho Ryu
Journal:  PLoS One       Date:  2016-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.